Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05107453Phase 4Completed
Phase 4, randomised trial of levobupivacaine in postoperative pain (2 arms), sponsored by AZ Maria Middelares. Primary endpoint: Analgesic effect of superficial SAPB in MICS at 48 hours. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05107453.